Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001396814-24-000131
Filing Date
2024-10-23
Accepted
2024-10-23 18:54:28
Documents
2
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1729724062.html 3  
1 FORM 3 wk-form3_1729724062.xml 3 1672
2 EX-24 crosspowerofattorney.htm EX-24 5833
  Complete submission text file 0001396814-24-000131.txt   9241
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1825 K STREET SUITE 510 WASHINGTON DC 20006
Business Address
Cross Shawn (Reporting) CIK: 0001734779 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35060 | Film No.: 241390275